NEW YORK (GenomeWeb News) – Gamma-Dynacare Medical Laboratories announced today the completion of its acquisition of a controlling interest in Impact Genetics.
Terms of the purchase were not disclosed.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.
President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.
Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.
Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.